ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 36 filers reported holding ASCENDIS PHARMA A/S in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $363,589 | -40.0% | 2,666 | -33.5% | 0.15% | -37.8% |
Q1 2024 | $606,343 | +8.4% | 4,011 | -9.7% | 0.24% | -1.2% |
Q4 2023 | $559,344 | +40.8% | 4,441 | +4.7% | 0.24% | +213.0% |
Q3 2023 | $397,127 | +59.1% | 4,241 | +51.7% | 0.08% | +83.3% |
Q2 2023 | $249,543 | +37.7% | 2,796 | +65.4% | 0.04% | +20.0% |
Q1 2023 | $181,202 | -12.2% | 1,690 | 0.0% | 0.04% | -12.5% |
Q4 2022 | $206,400 | +5.8% | 1,690 | -10.6% | 0.04% | +5.3% |
Q3 2022 | $195,000 | +10.8% | 1,890 | 0.0% | 0.04% | +8.6% |
Q2 2022 | $176,000 | -75.5% | 1,890 | -69.2% | 0.04% | -72.7% |
Q1 2022 | $719,000 | -12.8% | 6,129 | 0.0% | 0.13% | +3.2% |
Q4 2021 | $825,000 | -86.6% | 6,129 | -84.1% | 0.12% | -75.8% |
Q3 2021 | $6,160,000 | +1219.1% | 38,650 | +988.7% | 0.51% | +1247.4% |
Q2 2021 | $467,000 | +11.5% | 3,550 | +9.2% | 0.04% | +18.8% |
Q1 2021 | $419,000 | -27.4% | 3,250 | -89.5% | 0.03% | +14.3% |
Q1 2016 | $577,000 | +1.2% | 31,100 | 0.0% | 0.03% | +16.7% |
Q4 2015 | $570,000 | +3.6% | 31,100 | 0.0% | 0.02% | -4.0% |
Q3 2015 | $550,000 | -86.8% | 31,100 | -86.8% | 0.02% | -85.6% |
Q2 2015 | $4,165,000 | -67.2% | 235,560 | -67.8% | 0.17% | -63.9% |
Q1 2015 | $12,694,000 | – | 731,660 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |